Winbro Pharma Private Limited - Due diligence report

A 360° intelligence report on Winbro Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…

2003-12-05 Chennai, Tamil Nadu Active Unlisted Active Compliant
Share
WP Winbro Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Winbro Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
64/100
Trust Score
Moderate

Winbro Pharma Private Limited is assessed as Moderate with a Trust Score of 64/100. Winbro Pharma Private Limited is an active private limited indian non-government company incorporated in 2003, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 21 Jul 2026 from the latest processed filings. Winbro Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
64/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
45/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.

Charges position: 1 open (5.55 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RENGANATHAN PAPPU REDDIAR 01234567 Director 01/04/2018 6 yrs Approved
MALARSELVI RENGANATHAN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2019)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Windia Chemicals Private Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Windia Chemicals Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 45 · Distress 30
Growth signals & trust indicators
Asset base grew 38% - capacity expansion.
Operating for 22+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Outside liabilities up 1.42 in a year.
Negative net worth.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence68/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 4 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment44/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 5.55 Lakh already registered.
  • Compliance record supports lending.
Investor view36/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
05 May 2023
Director ceased
THUVAARAKKESH RAMANATHAN
31 Mar 2023
Share transfer (FY 2023)
24000.00000000 shares to WINDIA CHEMICALS PRIVATE LIMITED
Share transfer (FY 2023)
32000.00000000 shares to WINDIA CHEMICALS PRIVATE LIMITED
12 Apr 2022
Charge created
Hdfc Bank Limited - 5.55 Lakh
02 Nov 2020
Director appointed
MALARSELVI RENGANATHAN (Director)
30 Mar 2019
Director ceased
PANDURANGAN BALAKRISHNAN
30 Sep 2018
Director ceased
SELVAKUMAR SOMASUNDARAM
01 Apr 2018
Director ceased
PERUMAL ASAITHAMBI
29 Mar 2013
Securities allotted
50000.00 Equity Shares - 5.00 Lakh raised
05 Dec 2003
Incorporated
Registered with Roc Chennai
Director appointed
RENGANATHAN PAPPU REDDIAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Auroactive Pharma Private Limited U24230TG2020PTC138313 Hyderabad, Telangana, India
Oriental Matchem Ltd. U27109CT1990PLC009774 Bhilai, Chattisgarh, India
Fitcast Chemicals Private Limited U24231GJ1992PTC017293 Ahmedabad, Gujarat, India
Aksigen Pharmaceuticals Private Limited U24239MH1995PTC091631 Mumbai, Maharashtra, India
Ohc Innovations Private Limited U24290HP2021PTC009002 Paonta Sahib, Himachal Pradesh, India
People'S Pharmaceuticals Private Limited U24230MP2010PTC023140 Bhopal, Madhya Pradesh, India
Ishare Pharma Private Limited U74110UP2013PTC057953 Ghaziabad, Uttar Pradesh, India
Devi Pharmatech Private Limited U24100AP2020PTC116039 Visakhapatnam, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Winbro Pharma Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Winbro Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 45/100, margin trends, ownership structure and peer set for Winbro Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 64/100, distress signals and MSME payment-delay disclosures - know whether Winbro Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Winbro Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Winbro Pharma Private Limited an active company?

Winbro Pharma Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Winbro Pharma Private Limited financially healthy?

Winbro Pharma Private Limited has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Winbro Pharma Private Limited?

Its overall Trust Score is 64/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Winbro Pharma Private Limited?

The ultimate holding entity is Windia Chemicals Private Limited. 2 active director(s) are on record.

Does Winbro Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Winbro Pharma Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Winbro Pharma Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.